Literature DB >> 3843693

Papillary carcinoma.

A L Vickery, M L Carcangiu, J V Johannessen, M Sobrinho-Simoes.   

Abstract

In addition to a description of the basic criteria for the diagnosis of papillary carcinoma, a review of discussions by all workshop participants on the illustrative cases is presented. Areas of consensus included the following: classification of mixed papillary and follicular carcinomas as papillary, regardless of follicular dominance; recognition of three morphological variants--follicular, encapsulated, and diffuse sclerosing; nonspecificity of individual histological criteria, with the necessity to utilize a combination of characteristic features as guidelines for establishing a diagnosis; citing of nuclear features as probably the most important diagnostic criteria, ie, increased N/C ratio, irregularity in outline, and paleness of staining (ground glass appearance); grading of tumors on the basis of either cytological or architectural characteristics remains of unproven prognostic value. (Gross extent of tumor at the first operation remains the most valuable single prognostic criterion.); defining small carcinomas by size rather than using the imprecise term "occult" with its variable definitions including some clinically evident tumors; classifying as undifferentiated those carcinomas presenting a mixed papillary and anaplastic appearance at the time of the first operation, and retaining the papillary designation for papillary cancers which later undergo dedifferentiation; and recognition that thyroglobulin is a constant and keratin an inconstant tumor cell marker, with the latter not specific for distinguishing papillary carcinomas from follicular carcinomas or from hyperplastic adenomas.

Entities:  

Mesh:

Year:  1985        PMID: 3843693

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  34 in total

1.  Occult papillary microcarcinoma of the thyroid--a potential pitfall of fine needle aspiration cytology?

Authors:  H R Harach; E Saravia Day; S B Zusman
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 2.  How to define follicular thyroid carcinoma?

Authors:  Kurt Werner Schmid; Nadir Rashad Farid
Journal:  Virchows Arch       Date:  2006-02-28       Impact factor: 4.064

Review 3.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 4.  Diagnostic criteria in well-differentiated thyroid carcinomas.

Authors:  Elsa Fonseca; Paula Soares; Manuel Cardoso-Oliveira; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 5.  Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants.

Authors:  Alfred King-Yin Lam; Chung-Yau Lo; Karen Siu-Ling Lam
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

6.  Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Clara S Heffess
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

7.  Different CXCR4 expression according to various histologic subtype of papillary thyroid carcinoma.

Authors:  Dong Yeob Shin; Kwang Joon Kim; Cheol Ryong Ku; Mi Kyung Lee; Soo Il Jee; Woong Youn Chung; Eun Jig Lee
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

8.  Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.

Authors:  S Schröder; V Bay; K Dumke; B Kremens; H W Müller-Gärtner; W Böcker; H Kastendieck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

9.  Aberrant expression of HLA-DR antigen in diffuse sclerosing variant of papillary carcinoma of thyroid.

Authors:  X Matias-Guiu; J Esquius
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

10.  Diffuse sclerosing variant of papillary thyroid carcinoma with primary squamous cell carcinoma.

Authors:  N Kebapci; B Efe; S Kabukcuoglu; A Akalin; M Kebapci
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.